David Spiegel

David Spiegel
OccupationPsychiatrist
Academic background
Alma materHarvard Medical School
Academic work
InstitutionsStanford University School of Medicine

David Spiegel is an American psychiatrist and the Wilson Professor and Associate Chair of Psychiatry at Stanford University School of Medicine, where he is known for his research into psycho-oncology; the neurobiology of therapeutic hypnosis,[1][2] and the role of the mind-brain-body connection in cancer outcomes and management among other topics.[3][4][5] He directs the Stanford Center on Stress and Health[6] and is a recognized authority on hypnosis's clinical utility and neuroscience.[7][8][9]

  1. ^ Faerman, Afik; Spiegel, David (2021-03-11). "Shared cognitive mechanisms of hypnotizability with executive functioning and information salience". Scientific Reports. 11 (1): 5704. Bibcode:2021NatSR..11.5704F. doi:10.1038/s41598-021-84954-8. ISSN 2045-2322. PMC 7970985. PMID 33707531.
  2. ^ Williams, Sarah C. P. (July 28, 2016). "Study identifies brain areas altered during hypnotic trances". Stanford Medicine News Center (in Samoan). Retrieved 2022-08-22.
  3. ^ How do mind-body interventions affect breast cancer?. APA.
  4. ^ Huberman, Andrew (2022-02-21). "Dr. David Spiegel: Using Hypnosis to Enhance Mental & Physical Health & Performance". Huberman Lab. Retrieved 2022-08-22.
  5. ^ Brody, Jane E. (2021-10-04). "The Devastating Ways Depression and Anxiety Impact the Body". The New York Times. ISSN 0362-4331. Retrieved 2022-08-22.
  6. ^ Center on Stress and Health
  7. ^ Boodman, Sandra G. (April 13, 2004). "Research: Hypnosis Proven for Some Conditions, Untested for Others". Washington Post. Retrieved May 24, 2021.
  8. ^ "How Hypnosis Works, According to Science". Time. 28 April 2022. Retrieved 2022-08-22.
  9. ^ Goode, Erica (2016-07-29). "Is Hypnosis All in Your Head? Brain Scans Suggest Otherwise". The New York Times. ISSN 0362-4331. Retrieved 2022-08-22.